Antidepressant use and the risk of breast cancer: A non-association

被引:49
作者
Wang, PS
Walker, AM
Tsuang, MT
Orav, EJ
Levin, R
Avorn, J
机构
[1] Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Pharmacoepidemiol & Pharmacoecon, Boston, MA 02115 USA
[2] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA
[3] Harvard Univ, Sch Med, Brigham & Womens Hosp, Clin Epidemiol Sect, Boston, MA 02115 USA
[4] Harvard Univ, Sch Med, Massachusetts Mental Hlth Ctr, Boston, MA 02115 USA
关键词
antidepressant medications; breast cancer; risk factor;
D O I
10.1016/S0895-4356(00)00354-1
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Objective: Animal studies have suggested that some antidepressant medications may act as breast tumor promoters and recent epidemiologic studies of antidepressant use and breast cancer outcomes in humans have also reported such associations. Design: Retrospective cohort study, Study population: 38,273 women who filled a prescription for any of a number of antidepressants and 32,949 who filled a prescription for any other medication during 1989-1991; all were greater than or equal to 20. enrolled in Medicare, Medicaid or the Pharmaceutical Assistance to the Aged and Disabled (PAAD) programs of New Jersey, and free of evidence of breast cancer. Data collection: Antidepressant use was assessed over a period Lasting up to 24 months. Subjects were followed for a maximum of 7.5 years; those who had a first diagnosis of breast cancer in the New Jersey Cancer Registry at least 3 months after their index date were considered incident breast cancer cases. Other covariates. including demographic, clinical, and health care utilization variables were also assessed. Main outcome of interest: Adjusted hazard ratio (HR) of developing breast cancer, based on multivariable proportional hazards models. Results: Use of antidepressants was unrelated to the development of breast cancer (adjusted HR = 1.04: 95% CI 0.87-1.25). No elevated risks were found for specific antidepressants, including agents found to be breast tumor promoters in animal studies, as well as drugs thought to be associated with breast cancer in prior epidemiologic studies. There was no suggestion that breast cancer risks were increased with more intensive use of antidepressants or that antidepressant use is associated with a more severe stage of cancer at diagnosis. Conclusions: Despite recent reports from much smaller epidemiologic studies or laboratory animals, these results provide reassurance that antidepressant use is not associated with the development of breast cancer. (C) 2001 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:728 / 734
页数:7
相关论文
共 36 条
[1]  
[Anonymous], 1993, AM J PSYCHIAT, V150, P1
[2]  
[Anonymous], 1989, PHYS CURR PROC TERM
[3]   THE RELATION BETWEEN HEALTH-INSURANCE COVERAGE AND CLINICAL OUTCOMES AMONG WOMEN WITH BREAST-CANCER [J].
AYANIAN, JZ ;
KOHLER, BA ;
ABE, T ;
EPSTEIN, AM .
NEW ENGLAND JOURNAL OF MEDICINE, 1993, 329 (05) :326-331
[4]   BENIGN BREAST DISEASES, CARCINOMA IN-SITU, AND BREAST-CANCER RISK [J].
BODIAN, CA .
EPIDEMIOLOGIC REVIEWS, 1993, 15 (01) :177-187
[5]  
BRANDES LJ, 1992, CANCER RES, V52, P3796
[6]   ESTROGEN REPLACEMENT THERAPY AND BREAST-CANCER RISK [J].
BRINTON, LA ;
SCHAIRER, C .
EPIDEMIOLOGIC REVIEWS, 1993, 15 (01) :66-79
[7]   A NEW METHOD OF CLASSIFYING PROGNOSTIC CO-MORBIDITY IN LONGITUDINAL-STUDIES - DEVELOPMENT AND VALIDATION [J].
CHARLSON, ME ;
POMPEI, P ;
ALES, KL ;
MACKENZIE, CR .
JOURNAL OF CHRONIC DISEASES, 1987, 40 (05) :373-383
[8]   CELL-PROLIFERATION IN CARCINOGENESIS [J].
COHEN, SM ;
ELLWEIN, LB .
SCIENCE, 1990, 249 (4972) :1007-1011
[9]   THE USE OF ESTROGENS AND PROGESTINS AND THE RISK OF BREAST-CANCER IN POSTMENOPAUSAL WOMEN [J].
COLDITZ, GA ;
HANKINSON, SE ;
HUNTER, DJ ;
WILLETT, WC ;
MANSON, JE ;
STAMPFER, MJ ;
HENNEKENS, C ;
ROSNER, B ;
SPEIZER, FE .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 332 (24) :1589-1593
[10]  
Cotterchio M, 2000, AM J EPIDEMIOL, V151, P951, DOI 10.1093/oxfordjournals.aje.a010138